To the best of our knowledge, no prior reports have investigated the relationship between NAT2, CYP1A1, and CYP1A2 polymorphisms and HAAs as risk factors for prostate cancer in a Japanese population. The gene discussed is CYP1A1; the disease is Familial prostate cancer.